Healthcare - Biotechnology - NASDAQ - US
$ 0.6701
-6.12 %
$ 25.9 M
Market Cap
-0.24
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
17.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Athira Pharma, Inc.
ATHA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ATHA
EBIT FORECAST
EBIT Forecast Chart ATHA
NET INCOME FORECAST
Net Income Chart ATHA